Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3689453011 | Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
3689454017 | Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Is a | Aspirin and metoclopramide only product in oral dose form | true | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Is a | Analgesics with anti-emetics | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Is a | Aspirin- and metoclopramide-containing product | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has active ingredient | Metoclopramide | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has active ingredient | Prokinetic Agent | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has active ingredient | Aspirin | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has manufactured dose form | Sachet | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Is a | Metoclopramide-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Is a | Aspirin-containing product in oral dose form | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has manufactured dose form | Conventional release oral powder | true | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength denominator unit | Sachet | true | Inferred relationship | Some | 2 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has unit of presentation | Sachet | true | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength denominator unit | Sachet | true | Inferred relationship | Some | 1 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Is a | Lysine-containing product | false | Inferred relationship | Some | ||
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength numerator value | 10 | false | Inferred relationship | Some | 1 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has precise active ingredient | Aspirin DL-lysine | true | Inferred relationship | Some | 2 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has BoSS | Metoclopramide hydrochloride | true | Inferred relationship | Some | 1 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has BoSS | Aspirin DL-lysine | true | Inferred relationship | Some | 2 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has precise active ingredient | Metoclopramide hydrochloride | true | Inferred relationship | Some | 1 | |
Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet | Has presentation strength numerator value | 900 | false | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set